• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insiders Buying SMART Global Holdings And 2 Other Stocks

    4/12/24 7:17:24 AM ET
    $LEN
    $NEOG
    $SGH
    Homebuilding
    Consumer Discretionary
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $LEN alert in real time by email

    Although U.S. stocks closed mostly higher on Thursday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    Lennar

    • The Trade: Lennar Corporation (NYSE:LEN) Director Amy Banse acquired a total of 2,438 shares an average price of $157.00. To acquire these shares, it cost around $247,275.
    • What’s Happening: LP Building Solutions and Lennar reported a nationwide supply agreement.
    • What Lennar Does: Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name.

    SMART Global

    • The Trade: SMART Global Holdings, Inc. (NASDAQ:SGH) President and CEO Mark Adams acquired a total of 10,000 shares at an average price of
    • $18.79. To acquire these shares, it cost around $187,896.
    • What’s Happening: On April 9, The company reported quarterly earnings of 27 cents per share, beating the analyst consensus estimate of 25 cents by 8%.
    • What SMART Global Does: SMART Global Holdings Inc is a designer and manufacturer of electronic products focused on memory and computing technology areas.

    Don’t forget to check out our premarket coverage here

    Neogen

    • The Trade: Neogen Corporation (NASDAQ:NEOG) Director James C Borel bought a total of 7,500 shares at an average price of $13.06. To acquire these shares, it cost around $97,986.
    • What’s Happening: On April 9, Neogen reported worse than expected third-quarter FY2024 earnings and cut 2024 guidance.
    • What Neogen Does: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety.

     

    Check This Out: Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Friday

    Get the next $LEN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LEN
    $NEOG
    $SGH

    CompanyDatePrice TargetRatingAnalyst
    Lennar Corporation
    $LEN
    1/7/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    Lennar Corporation
    $LEN
    1/6/2026$122.00Buy → Neutral
    UBS
    Lennar Corporation
    $LEN
    12/18/2025$95.00Sector Perform → Underperform
    RBC Capital Mkts
    Lennar Corporation
    $LEN
    12/18/2025$92.00In-line → Underperform
    Evercore ISI
    Lennar Corporation
    $LEN
    12/18/2025$95.00Neutral → Underperform
    BofA Securities
    Lennar Corporation
    $LEN
    12/8/2025$98.00Equal Weight → Underweight
    Barclays
    Lennar Corporation
    $LEN
    12/4/2025$115.00Neutral → Underweight
    Analyst
    Lennar Corporation
    $LEN
    12/2/2025$96.00Sell
    BTIG Research
    More analyst ratings

    $LEN
    $NEOG
    $SGH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    "Trump Homes" Ignite a New Housing Trade

    DENVER, Feb. 04, 2026 (GLOBE NEWSWIRE) --  In a move that could reshape America's housing landscape, major builders are pitching "Trump Homes," a massive rent-to-own initiative aimed at tackling the affordability crisis with up to 1 million entry-level homes. Spearheaded by industry giants like Lennar (NYSE:LEN) and Taylor Morrison, the proposal envisions private investors funding the builds, with renters' payments accruing toward down payments after three years. This could unleash over $250 billion in housing development, blending private capital with White House-friendly policies amid sky-high home prices and interest rates. The plan, still in refinement and not yet under active White H

    2/4/26 9:35:49 AM ET
    $BLDR
    $LEN
    $RKT
    RETAIL: Building Materials
    Consumer Discretionary
    Homebuilding
    Finance: Consumer Services

    Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

    Neogen Corporation (NASDAQ:NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following intraarticular injections of this product, which is inconsistent with its labeled, intended use. To date, Neogen has not received reports of adverse events when used in a manner consistent with the labeled use. While the company's

    1/28/26 6:27:00 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Lennar Corporation Declares Quarterly Dividends

    MIAMI, Jan. 21, 2026 /PRNewswire/ -- Lennar Corporation (NYSE:LEN), one of the nation's leading homebuilders, announced that its Board of Directors has declared a quarterly cash dividend of $0.50 per share for both Class A and Class B common stock payable on February 19, 2026 to holders of record at the close of business on February 4, 2026. About LennarLennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-up and active adult homes primarily under the Lennar brand name. Lennar's Financial Services segment provides mortgage financing, title and closing services primarily for buyers of Lennar's homes a

    1/21/26 4:30:00 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    $LEN
    $NEOG
    $SGH
    SEC Filings

    View All

    SEC Form 13F-HR filed by Lennar Corporation

    13F-HR - LENNAR CORP /NEW/ (0000920760) (Filer)

    2/17/26 4:05:03 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    SEC Form 10-K filed by Lennar Corporation

    10-K - LENNAR CORP /NEW/ (0000920760) (Filer)

    1/28/26 4:54:24 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13D/A filed by Lennar Corporation

    SCHEDULE 13D/A - LENNAR CORP /NEW/ (0000920760) (Subject)

    1/13/26 7:30:15 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    $LEN
    $NEOG
    $SGH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP & Controller Collins David M covered exercise/tax liability with 3,011 shares, decreasing direct ownership by 6% to 49,619 units (SEC Form 4)

    4 - LENNAR CORP /NEW/ (0000920760) (Issuer)

    2/18/26 5:41:14 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Chief Legal Officer/Secretary Lee Martin Katherine covered exercise/tax liability with 3,955 shares, decreasing direct ownership by 7% to 55,611 units (SEC Form 4)

    4 - LENNAR CORP /NEW/ (0000920760) (Issuer)

    2/18/26 5:31:16 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    CEO Nassif Mikheal bought $252 worth of shares (23 units at $10.94) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    2/17/26 3:12:55 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $LEN
    $NEOG
    $SGH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lennar downgraded by Citizens JMP

    Citizens JMP downgraded Lennar from Mkt Outperform to Mkt Perform

    1/7/26 8:57:14 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Lennar downgraded by UBS with a new price target

    UBS downgraded Lennar from Buy to Neutral and set a new price target of $122.00

    1/6/26 8:46:59 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Lennar downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Lennar from Sector Perform to Underperform and set a new price target of $95.00

    12/18/25 9:01:04 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    $LEN
    $NEOG
    $SGH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Nassif Mikheal bought $252 worth of shares (23 units at $10.94) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    2/17/26 3:12:55 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    CEO Nassif Mikheal bought $486 worth of shares (49 units at $9.93) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    2/2/26 4:36:07 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    CEO Nassif Mikheal bought $1,279 worth of shares (137 units at $9.33) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    1/16/26 9:04:01 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $LEN
    $NEOG
    $SGH
    Financials

    Live finance-specific insights

    View All

    Lennar Corporation Declares Quarterly Dividends

    MIAMI, Jan. 21, 2026 /PRNewswire/ -- Lennar Corporation (NYSE:LEN), one of the nation's leading homebuilders, announced that its Board of Directors has declared a quarterly cash dividend of $0.50 per share for both Class A and Class B common stock payable on February 19, 2026 to holders of record at the close of business on February 4, 2026. About LennarLennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-up and active adult homes primarily under the Lennar brand name. Lennar's Financial Services segment provides mortgage financing, title and closing services primarily for buyers of Lennar's homes a

    1/21/26 4:30:00 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Neogen Announces Second-Quarter 2026 Results

    Revenue of $224.7 million, a decrease of 2.8% YoY; Core growth1 increased 2.9% YoY Net loss of $15.9 million; Adjusted Net Income1 of $22.6 million Adjusted EBITDA1 of $48.7 million; Adjusted EBITDA margin1 increased 470 bps sequentially Company hires key senior commercial leaders Petrifilm manufacturing transition remains on track Raising FY 2026 revenue and Adjusted EBITDA guidance 1 Non-GAAP financial measures; see explanations and reconciliations that follow Neogen Corporation (NASDAQ:NEOG) announced today the results of the second quarter ended November 30, 2025. "I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic tr

    1/8/26 7:00:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Neogen Announces Second-Quarter Earnings Release Date

    Neogen® Corporation (NASDAQ:NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-800-549-8228 International: (+1) 646-564-2877 Conference ID: 82072 The live webcast can be accessed through Neogen's Investor Relations webpage, investors.neogen.com, under the "Events & Presentations" subheading. A replay of the conference call and webcast will be available shortly following the conclusion of the call and c

    12/18/25 9:00:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $LEN
    $NEOG
    $SGH
    Leadership Updates

    Live Leadership Updates

    View All

    Lennar Announces the Retirement of Jonathan Jaffe, Co-CEO and President

    MIAMI, Nov. 14, 2025 /PRNewswire/ -- Lennar Corporation (NYSE:LEN), one of the nation's leading homebuilders, today announced that Lennar Co-Chief Executive Officer and President Jon Jaffe will retire effective December 31, 2025, following a distinguished 42-year career with the Company, and he will also step down from his role as a Director of the Board of the Company. After Mr. Jaffe's retirement, Stuart Miller will continue to serve as Executive Chairman and serve as Chief Executive Officer of Lennar, with no plans to replace Mr. Jaffe's role. Mr. Jaffe joined Lennar in 1983 as an assistant superintendent in Tampa, and through decades of hard work, unwavering commitment, and numerous val

    11/14/25 5:20:00 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer

    Neogen® Corporation (NASDAQ:NEOG), a global leader of food safety solutions, is pleased to announce the appointment of Bryan Riggsbee as its new Chief Financial Officer effective November 3, 2025. Riggsbee will oversee Neogen's global finance organization and join the company's Executive Leadership Team, reporting directly to Chief Executive Officer Mike Nassif. To ensure a smooth transition, David Naemura is expected to remain with the Company until the end of the calendar year. Riggsbee brings over 25 years of financial leadership experience across the diagnostics and healthcare industries. He joins Neogen from bioMérieux where he served as Chief Financial Officer of its $2 billion Nort

    10/30/25 8:45:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Neogen Announces Board Transition with Appointment of Avi Pelossof and the Retirement of William Boehm

    Neogen® Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, announced today that William Boehm has chosen to retire from the Company's Board of Directors, effective October 23, 2025. Mr. Boehm has served on Neogen's Board since 2011 and currently serves on the Compensation & Talent Management Committee and chairs the Audit Committee. "On behalf of the entire Board and leadership team, I want to express our deep gratitude to Bill for his many years of dedicated service to Neogen," said James C. Borel, Chair of the Neogen Board of Directors. "Bill's insight, guidance, and commitment to our mission have been invaluable in shaping Neogen's path forward. His contributions

    8/14/25 4:15:00 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $LEN
    $NEOG
    $SGH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Neogen Corporation

    SC 13G - NEOGEN CORP (0000711377) (Subject)

    11/14/24 4:28:12 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G filed by Neogen Corporation

    SC 13G - NEOGEN CORP (0000711377) (Subject)

    11/14/24 11:16:20 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G filed by Lennar Corporation

    SC 13G - LENNAR CORP /NEW/ (0000920760) (Subject)

    11/12/24 10:32:12 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary